Me's once rising star has dimmed amid a series of setbacks, leading some users to wonder what will happen to their genetic ...

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

When it comes to breast cancer, good news is always welcome. Texas Oncology – Paris has some good news — in fact, it has ...

Women have long understood the importance of early detection of breast cancer, a leading cause of mortality in women.

Dr. Peters added for the average woman with no family history of breast cancer or other risks, they should start getting ...

“While we will delete the majority of your personal information, we are required to retain some information to comply with ...

Charlotte Division and Department of Health and Human Services, Office of Inspector General (HHS-OIG) investigated the case.

After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...

M. Michele Blackwood, MD, FACS, provided an overview of the significant advancements with personalized medicine with genomic ...

Breast cancer is the second most common cancer for women in the United States. It’s also why it’s now recommended that all ...

I acted calm and unsurprised when the OB/GYN told me that I had tested positive for the BRCA1 gene mutation. But I was scared.

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a new partnership with AstraZeneca, a ...